Resveratrol inhibits monocrotaline‐induced pulmonary arterial remodeling by suppression of SphK1‐mediated NF‐&kgr;B activation

[1]  R. Huddleston.  Structure , 2018, Jane Austen's Style.

[2]  Lei Yang,et al.  Resveratrol inhibits hypoxia-induced proliferation and migration of pulmonary artery vascular smooth muscle cells by inhibiting the phosphoinositide 3-kinase/protein kinase B signaling pathway , 2017, Molecular medicine reports.

[3]  Lei Yu,et al.  Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1 , 2017, Cellular Physiology and Biochemistry.

[4]  Iya Khalil,et al.  Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells. , 2017, Cancer research.

[5]  Yinxia Wu,et al.  Inhibition of ubiquitin proteasome function prevents monocrotaline‐induced pulmonary arterial remodeling , 2017, Life sciences.

[6]  J. González‐Gallego,et al.  Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1‐phosphate signaling pathway in a mouse model of diethylnitrosamine‐induced hepatocellular carcinoma , 2017, Journal of pineal research.

[7]  A. Mondal,et al.  Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  Haifeng Jin,et al.  Grape seed procyanidin extract attenuates hypoxic pulmonary hypertension by inhibiting oxidative stress and pulmonary arterial smooth muscle cells proliferation. , 2016, The Journal of nutritional biochemistry.

[9]  S. Joshi,et al.  Sphingosine-1-Phosphate is Involved in the Occlusive Arteriopathy of Pulmonary Arterial Hypertension , 2016, Pulmonary circulation.

[10]  R. Machado,et al.  PDGF induces SphK1 expression via Egr-1 to promote pulmonary artery smooth muscle cell proliferation. , 2016, American journal of physiology. Cell physiology.

[11]  Wei Li,et al.  Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling , 2016, Oncogene.

[12]  E. Gao,et al.  Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction. , 2016, American Journal of Physiology. Heart and Circulatory Physiology.

[13]  P. Elias,et al.  Sphingosine kinase 1 activation enhances epidermal innate immunity through sphingosine-1-phosphate stimulation of cathelicidin production. , 2015, Journal of dermatological science.

[14]  J. Garcia,et al.  The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension. , 2014, American journal of respiratory and critical care medicine.

[15]  M. Okada,et al.  A novel adipocytokine, omentin, inhibits monocrotaline-induced pulmonary arterial hypertension in rats. , 2014, Biochemical and biophysical research communications.

[16]  Xiaomei Meng,et al.  Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signaling. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[17]  Y. Janssen-Heininger,et al.  Inhibition of Nuclear Factor-&kgr;B in the Lungs Prevents Monocrotaline-Induced Pulmonary Hypertension in Mice , 2014, Hypertension.

[18]  W. Seeger,et al.  Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling. , 2013, Antioxidants & redox signaling.

[19]  A. Itai,et al.  Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354. , 2013, Cardiovascular research.

[20]  H. Yıldırım,et al.  Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension. , 2013, Pathology, research and practice.

[21]  M. Inagaki,et al.  Cell cycle progression by the repression of primary cilia formation in proliferating cells , 2013, Cellular and Molecular Life Sciences.

[22]  Wang Wang,et al.  Wnt5a inhibits hypoxia-induced pulmonary arterial smooth muscle cell proliferation by downregulation of β-catenin. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[23]  Eugene Y. Kim,et al.  Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. , 2013, Cancer cell.

[24]  S. Pyne,et al.  Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival , 2012, British journal of pharmacology.

[25]  K. Lynch.  Building a better sphingosine kinase-1 inhibitor. , 2012, The Biochemical journal.

[26]  G. Robertson,et al.  Targeting sphingosine kinase‐1 to inhibit melanoma , 2012, Pigment cell & melanoma research.

[27]  F. Şahin,et al.  Resveratrol Triggers Apoptosis Through Regulating Ceramide Metabolizing Genes in Human K562 Chronic Myeloid Leukemia Cells , 2011, Nutrition and cancer.

[28]  Libing Song,et al.  Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF-κB Pathway in Human Non–Small Cell Lung Cancer , 2011, Clinical Cancer Research.

[29]  N. Morrell,et al.  Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension. , 2010, Comprehensive Physiology.

[30]  Xian-sheng Liu,et al.  Plasmid-based short hairpin RNA against cyclin D1 attenuated pulmonary vascular remodeling in smoking rats. , 2010, Microvascular research.

[31]  S. Pyne,et al.  Sphingosine 1-phosphate and cancer , 2010, Nature Reviews Cancer.

[32]  J. Slotte,et al.  An autocrine sphingosine-1-phosphate signaling loop enhances NF-κB-activation and survival , 2010, BMC Cell Biology.

[33]  S. Milstien,et al.  Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts. , 2009, Cancer research.

[34]  R. Arora,et al.  Resveratrol: biologic and therapeutic implications. , 2009, Journal of the cardiometabolic syndrome.

[35]  Y. Zeng,et al.  Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients , 2009, Clinical Cancer Research.

[36]  Z. Ungvari,et al.  Resveratrol Prevents Monocrotaline‐induced Pulmonary Hypertension in Rats , 2008, Hypertension.

[37]  M. Kazanietz,et al.  Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1. , 2008, The Biochemical journal.

[38]  A. Mizoguchi,et al.  A Nuclear Factor-κB Inhibitor Pyrrolidine Dithiocarbamate Ameliorates Pulmonary Hypertension in Rats , 2007 .

[39]  M. Frid,et al.  Hypoxia-induced Pulmonary Vascular Remodeling Cellular and Molecular Mechanisms Reviews , 2022 .

[40]  M. Mcgoon,et al.  Pulmonary Arterial Hypertension , 2006, Circulation.

[41]  J. Becquemin,et al.  Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. , 2005, Journal of vascular surgery.

[42]  Korey R. Johnson,et al.  Immunohistochemical Distribution of Sphingosine Kinase 1 in Normal and Tumor Lung Tissue , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[43]  J. Loscalzo,et al.  Pulmonary arterial hypertension. , 2004, Annals of medicine.

[44]  M. Humbert,et al.  Cellular and molecular pathobiology of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[45]  N. Cheshire,et al.  Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Z. Estrov,et al.  Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. , 2003, Blood.

[47]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[48]  M. Davies,et al.  Sphingosine-1-Phosphate Induces Gαi-Coupled, PI3K/ras-Dependent Smooth Muscle Cell Migration☆ , 2002 .

[49]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[50]  Claus Scheidereit,et al.  NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.

[51]  W. Steudel,et al.  alpha-smooth-muscle actin and microvascular precursor smooth-muscle cells in pulmonary hypertension. , 1999, American journal of respiratory cell and molecular biology.

[52]  S. Milstien,et al.  Sphingosine-1-phosphate in chronic intestinal inflammation and cancer. , 2014, Advances in biological regulation.

[53]  L. Cowart,et al.  Sphingolipids in obesity, type 2 diabetes, and metabolic disease. , 2013, Handbook of experimental pharmacology.

[54]  M. Shakibaei,et al.  Resveratrol addiction: to die or not to die. , 2009, Molecular nutrition & food research.

[55]  A. Mizoguchi,et al.  A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. , 2007, Chest.

[56]  C. Swanton.  Cell-cycle targeted therapies. , 2004, The Lancet. Oncology.

[57]  Chenguang Wang,et al.  Signal transduction mediated by cyclin D1: from mitogens to cell proliferation: a molecular target with therapeutic potential. , 2004, Cancer treatment and research.

[58]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[59]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.